-
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test.
-
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011.
-
In one of its final acts, the lame-duck 112th Congress did something unprecedented over its two-year term: It expanded access to publicly financed abortion, ever so slightly.
-
-
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer.
-
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT).
-
Contraceptive injectables are a popular form of birth control for women around the world, with more than 35 million women relying on the method.
-
The U.S. Preventive Services Task Force (USPSTF) has just released its final recommendation statement on screening for HIV, and it recommends that clinicians screen all people ages 15 to 65, as well as younger adolescents and older adults who are at an increased risk for HIV infection, such as those who engage in unprotected vaginal or anal intercourse, use injection drugs, or are men who have sex with men.1
-
Five years after Australia launched a national human papillomavirus (HPV) vaccination program in young women, data indicates that genital wart cases have dropped not only among women, but heterosexual men as well.1
-
The National Institute of Allergy and Infectious Diseases (NIAID) is halting the administration of injections in the clinical trial of an investigational HIV vaccine regimen after a scheduled interim review data indicated the regimen did not prevent HIV infection, nor did it reduce viral load among vaccine recipients who became infected with HIV.